Type 2 Diabetes Mellitus Without Vascular Complications and Ischemia Modified Albumin
Dahiya, K.; Aggarwal, K.; Seth, S.; Singh, V.; Sharma, T.K.
Clinical Laboratory 56(5-6): 187-190
2010
ISSN/ISBN: 1433-6510 PMID: 20575465 Document Number: 15893
Ischemia modified albumin (IMA) is a proven cardiac marker but its role in type 2 diabetes mellitus without vascular complications has not been reported yet. Therefore, IMA was estimated in 60 newly diagnosed patients of type 2 diabetes mellitus and 30 healthy controls along with HbA1C and other investigations (to rule out vascular complications). There was no significant change in IMA levels in type 2 diabetic patients as compared to controls. No correlation could be found between IMA levels and HbA1C. We conclude that IMA levels are not affected in type 2 diabetes mellitus before the onset of vascular complications.
Document emailed within 1 workday
